Cargando…
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms
BACKGROUND: The index case is a 21‐year‐old Italian woman with a mild hemorrhagic syndrome and von Willebrand factor antigen (VWF:Ag) = 34.3 U/dl, VWF recombinant glycoprotein Ib (VWF:GpIbR) = 32.8 U/dl, and factor VIII (FVIII) = 55.3 IU/dl. AIMS: The aim of this study is to characterize from a gene...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545986/ https://www.ncbi.nlm.nih.gov/pubmed/35596664 http://dx.doi.org/10.1111/jth.15765 |
_version_ | 1784804940011536384 |
---|---|
author | Sacco, Monica Lancellotti, Stefano Branchini, Alessio Tardugno, Maira Testa, Maria Francesca Lunghi, Barbara Bernardi, Francesco Pinotti, Mirko Giusti, Betti Castaman, Giancarlo De Cristofaro, Raimondo |
author_facet | Sacco, Monica Lancellotti, Stefano Branchini, Alessio Tardugno, Maira Testa, Maria Francesca Lunghi, Barbara Bernardi, Francesco Pinotti, Mirko Giusti, Betti Castaman, Giancarlo De Cristofaro, Raimondo |
author_sort | Sacco, Monica |
collection | PubMed |
description | BACKGROUND: The index case is a 21‐year‐old Italian woman with a mild hemorrhagic syndrome and von Willebrand factor antigen (VWF:Ag) = 34.3 U/dl, VWF recombinant glycoprotein Ib (VWF:GpIbR) = 32.8 U/dl, and factor VIII (FVIII) = 55.3 IU/dl. AIMS: The aim of this study is to characterize from a genetic and biochemical standpoint this low VWF phenotype. METHODS: Coagulation and biochemical methods were used to study the structural and functional pattern of VWF multimers in the index case’s plasma. Recombinant wild‐type and p.P1127S VWF variants were produced using human embryonic kidney (HEK)‐293 cells. In addition, genetic screening was carried out to detect single nucleotide variants of some scavenger VWF/FVIII receptor genes such as CLEC4M, STAB2, and ASGR2. RESULTS: Genetic investigation revealed that the index case inherited from her mother the heterozygous missense mutation c.3379C > T (VWF exon 25), causing the p.P1127S substitution in the VWF D′D3 domain. The index case was also homozygous for the scavenger receptor ASGR2 c.‐95 CC‐genotype. Desmopressin normalized the VWF level of the patient, although its clearance was faster (t (1/2) = 6.7 h) than in normal subjects (t (1/2) = 12 ± 0.7 h). FVIII‐VWF interaction, A Disintegrin And Metalloprotease with ThromboSpondin type 1 motif‐13 levels, ristocetin‐induced‐platelet‐aggregation, and VWF multimeric pattern were normal. The p.P1127S variant was normally synthesized and secreted by HEK‐293 cells, and molecular modeling predicts a conformational change showing higher affinity for the macrophagic scavenger receptor lipoprotein receptor‐related protein 1 (LRP1), as also experimentally verified. CONCLUSIONS: The p.P1127S variant may cause a low VWF phenotype, stemming from an increased VWF affinity for the scavenger receptor LRP1 and, consequently, an accelerated clearance of VWF. |
format | Online Article Text |
id | pubmed-9545986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95459862022-10-14 The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms Sacco, Monica Lancellotti, Stefano Branchini, Alessio Tardugno, Maira Testa, Maria Francesca Lunghi, Barbara Bernardi, Francesco Pinotti, Mirko Giusti, Betti Castaman, Giancarlo De Cristofaro, Raimondo J Thromb Haemost HAEMOSTASIS BACKGROUND: The index case is a 21‐year‐old Italian woman with a mild hemorrhagic syndrome and von Willebrand factor antigen (VWF:Ag) = 34.3 U/dl, VWF recombinant glycoprotein Ib (VWF:GpIbR) = 32.8 U/dl, and factor VIII (FVIII) = 55.3 IU/dl. AIMS: The aim of this study is to characterize from a genetic and biochemical standpoint this low VWF phenotype. METHODS: Coagulation and biochemical methods were used to study the structural and functional pattern of VWF multimers in the index case’s plasma. Recombinant wild‐type and p.P1127S VWF variants were produced using human embryonic kidney (HEK)‐293 cells. In addition, genetic screening was carried out to detect single nucleotide variants of some scavenger VWF/FVIII receptor genes such as CLEC4M, STAB2, and ASGR2. RESULTS: Genetic investigation revealed that the index case inherited from her mother the heterozygous missense mutation c.3379C > T (VWF exon 25), causing the p.P1127S substitution in the VWF D′D3 domain. The index case was also homozygous for the scavenger receptor ASGR2 c.‐95 CC‐genotype. Desmopressin normalized the VWF level of the patient, although its clearance was faster (t (1/2) = 6.7 h) than in normal subjects (t (1/2) = 12 ± 0.7 h). FVIII‐VWF interaction, A Disintegrin And Metalloprotease with ThromboSpondin type 1 motif‐13 levels, ristocetin‐induced‐platelet‐aggregation, and VWF multimeric pattern were normal. The p.P1127S variant was normally synthesized and secreted by HEK‐293 cells, and molecular modeling predicts a conformational change showing higher affinity for the macrophagic scavenger receptor lipoprotein receptor‐related protein 1 (LRP1), as also experimentally verified. CONCLUSIONS: The p.P1127S variant may cause a low VWF phenotype, stemming from an increased VWF affinity for the scavenger receptor LRP1 and, consequently, an accelerated clearance of VWF. John Wiley and Sons Inc. 2022-06-09 2022-08 /pmc/articles/PMC9545986/ /pubmed/35596664 http://dx.doi.org/10.1111/jth.15765 Text en © 2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | HAEMOSTASIS Sacco, Monica Lancellotti, Stefano Branchini, Alessio Tardugno, Maira Testa, Maria Francesca Lunghi, Barbara Bernardi, Francesco Pinotti, Mirko Giusti, Betti Castaman, Giancarlo De Cristofaro, Raimondo The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms |
title | The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms |
title_full | The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms |
title_fullStr | The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms |
title_full_unstemmed | The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms |
title_short | The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms |
title_sort | p.p1127s pathogenic variant lowers von willebrand factor levels through higher affinity for the macrophagic scavenger receptor lrp1: clinical phenotype and pathogenic mechanisms |
topic | HAEMOSTASIS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545986/ https://www.ncbi.nlm.nih.gov/pubmed/35596664 http://dx.doi.org/10.1111/jth.15765 |
work_keys_str_mv | AT saccomonica thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT lancellottistefano thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT branchinialessio thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT tardugnomaira thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT testamariafrancesca thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT lunghibarbara thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT bernardifrancesco thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT pinottimirko thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT giustibetti thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT castamangiancarlo thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT decristofaroraimondo thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT saccomonica pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT lancellottistefano pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT branchinialessio pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT tardugnomaira pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT testamariafrancesca pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT lunghibarbara pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT bernardifrancesco pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT pinottimirko pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT giustibetti pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT castamangiancarlo pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms AT decristofaroraimondo pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms |